SAN DIEGO – November 26, 2013 — OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced it will be presenting at the Sixth Annual LD Micro Conference.
Punit Dhillon, President and CEO of OncoSec Medical, will provide a company overview and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
The presentation will take place on Wednesday, December 4 at 12 p.m. at the Luxe Sunset Bel Air Hotel in Los Angeles, California.
About the LD Micro Conference
The LD Micro conference hosts over 230 companies in the small cap and micro cap space. The three-day event brings innovative companies together with a tight-knit and loyal investor base. To find out more about the conference, visit the website.
SAN DIEGO – November 27, 2012 — OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that the company will provide an overview of its technologies, development programs, and outlook at the following investor conferences in upcoming weeks:
New York Society of Security Analysts (NYSSA) Life Sciences Conference, NYSSA Conference Center, 1540 Broadway, New York, NY, November 29th at 9:30 AM ET
Presentation by: Veronica Vallejo, CPA, Vice President of Finance
LD Micro Conference, Luxe Sunset Bel Air Hotel, 11461 Sunset Boulevard, Los Angeles, CA, December 5th at 11:00 AM PT
Presentation by: Punit Dhillon, President & CEO